These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 26289418

  • 21. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
    Murgia S, Quattrocchio G, Forneris G, Pozzato M, Fenoglio R, Ferro M, De Simone E, Del Vecchio G, Di Benedetto C, Roccatello D.
    J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
    [Abstract] [Full Text] [Related]

  • 22. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.
    Hutchison CA, Cockwell P, Stringer S, Bradwell A, Cook M, Gertz MA, Dispenzieri A, Winters JL, Kumar S, Rajkumar SV, Kyle RA, Leung N.
    J Am Soc Nephrol; 2011 Jun; 22(6):1129-36. PubMed ID: 21511832
    [Abstract] [Full Text] [Related]

  • 23. Myeloma light chain cast nephropathy, a review.
    Sathick IJ, Drosou ME, Leung N.
    J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
    [Abstract] [Full Text] [Related]

  • 24. Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors.
    Rodrigues L, Neves M, Sá H, Gomes H, Pratas J, Campos M.
    Eur J Intern Med; 2014 Sep; 25(7):652-6. PubMed ID: 25034390
    [Abstract] [Full Text] [Related]

  • 25. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
    Donati G, Zappulo F, Croci Chiocchini AL, Comai G, Zamagni E, La Manna G.
    Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
    [Abstract] [Full Text] [Related]

  • 26. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
    Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, Eladari D.
    Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.
    Bridoux F, Fermand JP.
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):333-41. PubMed ID: 22920644
    [Abstract] [Full Text] [Related]

  • 29. Long-term fate of renal function after open surgery for juxtarenal and pararenal aortic aneurysm.
    Sugimoto M, Takahashi N, Niimi K, Kodama A, Banno H, Komori K.
    J Vasc Surg; 2018 Apr; 67(4):1042-1050. PubMed ID: 28964618
    [Abstract] [Full Text] [Related]

  • 30. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
    Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL.
    Kidney Int; 2008 Jun; 73(11):1282-8. PubMed ID: 18385667
    [Abstract] [Full Text] [Related]

  • 31. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW, Cohen EP, Shirali A, Abudayyeh A, American Society of Nephrology Onco-Nephrology Forum.
    Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2273-2279. PubMed ID: 27526708
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct 07; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 34. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N, Behrens J.
    Adv Chronic Kidney Dis; 2012 Sep 07; 19(5):297-302. PubMed ID: 22920640
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.
    Shum HP, Chan KC, Chow CC, Kho BC, Yan WW.
    Hong Kong Med J; 2010 Dec 07; 16(6):489-92. PubMed ID: 21135429
    [Abstract] [Full Text] [Related]

  • 37. Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.
    Ludwig H, Rauch E, Kuehr T, Adam Z, Weißmann A, Kasparu H, Autzinger EM, Heintel D, Greil R, Poenisch W, Müldür E, Zojer N.
    Haematologica; 2015 Mar 07; 100(3):385-91. PubMed ID: 25398836
    [Abstract] [Full Text] [Related]

  • 38. [The kidney in multiple myeloma. The physiopathological and clinical aspects].
    Vivaldi P, Comotti C, Pedrazzoli M.
    Recenti Prog Med; 1994 Feb 07; 85(2):123-33. PubMed ID: 8184190
    [Abstract] [Full Text] [Related]

  • 39. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.
    Hutchison CA, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A, Herrera GA, Lachmann H, Sanders PW, International Kidney and Monoclonal Gammopathy Research Group.
    Nat Rev Nephrol; 2011 Nov 01; 8(1):43-51. PubMed ID: 22045243
    [Abstract] [Full Text] [Related]

  • 40. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK, Yang AH, Lai HC, Lin BS.
    BMC Nephrol; 2017 May 25; 18(1):170. PubMed ID: 28545410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.